Form 4 for IDXX Idexx Laboratories
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001567619-22-004965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-17 | 2022-02-15 | IDXX | AYERS JONATHAN W | Dir | S - Sale | $509.70 | -250 | 629.5K | -0.0% | -$127.4K | |
| 2022-02-17 | 2022-02-11 | IDXX | AYERS JONATHAN W | Dir | G - Gift | $0.00 | -8,000 | 629.7K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | S | D | 250 | $509.70 | 629,490 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-11 | G | D | 8,000 | $0.00 | 629,740 | D | — | — |